CASI Annual Cash & Cash Equivalents
$17.08 M
-$30.03 M-63.74%
31 December 2023
Summary:
As of January 21, 2025, CASI annual cash & cash equivalents is $17.08 million, with the most recent change of -$30.03 million (-63.74%) on December 31, 2023. During the last 3 years, it has fallen by -$39.98 million (-70.06%). CASI annual cash & cash equivalents is now -79.71% below its all-time high of $84.20 million, reached on December 31, 2018.CASI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Quarterly Cash And Cash Equivalents
$16.54 M
+$7.00 M+73.47%
01 September 2024
Summary:
As of January 21, 2025, CASI quarterly cash and cash equivalents is $16.54 million, with the most recent change of +$7.00 million (+73.47%) on September 1, 2024. Over the past year, it has dropped by -$546.00 thousand (-3.20%). CASI quarterly cash and cash equivalents is now -83.42% below its all-time high of $99.73 million, reached on March 31, 2019.CASI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -63.7% | -3.2% |
3 y3 years | -70.1% | -3.2% |
5 y5 years | -79.7% | -3.2% |
CASI Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -63.7% | at low | -64.9% | +73.5% |
5 y | 5-year | -70.1% | at low | -77.8% | +73.5% |
alltime | all time | -79.7% | +1480.9% | -83.4% | +1430.3% |
CASI Pharmaceuticals Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $16.54 M(+73.5%) |
June 2024 | - | $9.53 M(-21.9%) |
Mar 2024 | - | $12.20 M(-28.6%) |
Dec 2023 | $17.08 M(-63.7%) | $17.08 M(-14.5%) |
Sept 2023 | - | $19.98 M(+18.1%) |
June 2023 | - | $16.91 M(+1.9%) |
Mar 2023 | - | $16.59 M(-64.8%) |
Dec 2022 | $47.11 M(+21.7%) | $47.11 M(+76.2%) |
Sept 2022 | - | $26.74 M(+41.8%) |
June 2022 | - | $18.86 M(-35.5%) |
Mar 2022 | - | $29.26 M(-24.4%) |
Dec 2021 | $38.70 M(-32.2%) | $38.70 M(-27.1%) |
Sept 2021 | - | $53.13 M(-12.0%) |
June 2021 | - | $60.36 M(-11.4%) |
Mar 2021 | - | $68.12 M(+19.4%) |
Dec 2020 | $57.06 M(+6.4%) | $57.06 M(-23.5%) |
Sept 2020 | - | $74.59 M(+66.2%) |
June 2020 | - | $44.89 M(-16.7%) |
Mar 2020 | - | $53.88 M(+0.5%) |
Dec 2019 | $53.62 M(-36.3%) | $53.62 M(-15.2%) |
Sept 2019 | - | $63.24 M(-10.0%) |
June 2019 | - | $70.25 M(-29.6%) |
Mar 2019 | - | $99.73 M(+18.4%) |
Dec 2018 | $84.20 M(+93.6%) | $84.20 M(-14.8%) |
Sept 2018 | - | $98.87 M(+49.3%) |
June 2018 | - | $66.22 M(+32.7%) |
Mar 2018 | - | $49.89 M(+14.7%) |
Dec 2017 | $43.49 M(+60.5%) | $43.49 M(+101.0%) |
Sept 2017 | - | $21.64 M(-7.4%) |
June 2017 | - | $23.36 M(-8.5%) |
Mar 2017 | - | $25.53 M(-5.8%) |
Dec 2016 | $27.09 M(+428.0%) | $27.09 M(+12.2%) |
Sept 2016 | - | $24.14 M(+30.2%) |
June 2016 | - | $18.53 M(+32.9%) |
Mar 2016 | - | $13.94 M(+171.8%) |
Dec 2015 | $5.13 M(-51.9%) | $5.13 M(-20.1%) |
Sept 2015 | - | $6.42 M(-19.2%) |
June 2015 | - | $7.95 M(-15.9%) |
Mar 2015 | - | $9.46 M(-11.3%) |
Dec 2014 | $10.67 M(-29.5%) | $10.67 M(-9.7%) |
Sept 2014 | - | $11.82 M(-9.7%) |
June 2014 | - | $13.08 M(-7.9%) |
Mar 2014 | - | $14.20 M(-6.2%) |
Dec 2013 | $15.13 M(+88.0%) | $15.13 M(-4.7%) |
Sept 2013 | - | $15.87 M(-7.8%) |
June 2013 | - | $17.22 M(-5.7%) |
Mar 2013 | - | $18.27 M(+127.0%) |
Dec 2012 | $8.05 M(+644.9%) | $8.05 M(-8.7%) |
Sept 2012 | - | $8.81 M(-12.4%) |
June 2012 | - | $10.06 M(-11.3%) |
Mar 2012 | - | $11.35 M(+949.9%) |
Dec 2011 | $1.08 M(-77.9%) | $1.08 M(-45.6%) |
Sept 2011 | - | $1.99 M(-47.7%) |
June 2011 | - | $3.80 M(-20.8%) |
Mar 2011 | - | $4.80 M(-1.7%) |
Dec 2010 | $4.89 M | $4.89 M(-41.7%) |
Sept 2010 | - | $8.39 M(+4.9%) |
Date | Annual | Quarterly |
---|---|---|
June 2010 | - | $7.99 M(-17.2%) |
Mar 2010 | - | $9.65 M(+52.8%) |
Dec 2009 | $6.31 M(-62.3%) | $6.31 M(-29.7%) |
Sept 2009 | - | $8.97 M(-15.2%) |
June 2009 | - | $10.58 M(-14.0%) |
Mar 2009 | - | $12.30 M(-26.5%) |
Dec 2008 | $16.74 M(-43.6%) | $16.74 M(+50.8%) |
Sept 2008 | - | $11.10 M(-32.4%) |
June 2008 | - | $16.42 M(+3.3%) |
Mar 2008 | - | $15.89 M(-46.4%) |
Dec 2007 | $29.68 M(+42.0%) | $29.68 M(+1.7%) |
Sept 2007 | - | $29.17 M(+158.7%) |
June 2007 | - | $11.28 M(-27.0%) |
Mar 2007 | - | $15.44 M(-26.1%) |
Dec 2006 | $20.90 M(+83.2%) | $20.90 M(-6.1%) |
Sept 2006 | - | $22.24 M(+64.9%) |
June 2006 | - | $13.49 M(-35.2%) |
Mar 2006 | - | $20.80 M(+82.4%) |
Dec 2005 | $11.41 M(-44.1%) | $11.41 M(-37.9%) |
Sept 2005 | - | $18.37 M(+118.3%) |
June 2005 | - | $8.42 M(-60.1%) |
Mar 2005 | - | $21.07 M(+3.1%) |
Dec 2004 | $20.43 M(-41.3%) | $20.43 M(+146.0%) |
Sept 2004 | - | $8.30 M(-38.8%) |
June 2004 | - | $13.56 M(-48.4%) |
Mar 2004 | - | $26.30 M(-24.5%) |
Dec 2003 | $34.81 M(+44.6%) | $34.81 M(+86.3%) |
Sept 2003 | - | $18.69 M(+4.5%) |
June 2003 | - | $17.88 M(+172.8%) |
Mar 2003 | - | $6.55 M(-72.8%) |
Dec 2002 | $24.07 M(-41.8%) | $24.07 M(+402.1%) |
Sept 2002 | - | $4.79 M(-57.9%) |
June 2002 | - | $11.37 M(-56.8%) |
Mar 2002 | - | $26.30 M(-36.4%) |
Dec 2001 | $41.39 M(+68.9%) | $41.39 M(+8.7%) |
Sept 2001 | - | $38.09 M(+39.4%) |
June 2001 | - | $27.32 M(-33.1%) |
Mar 2001 | - | $40.84 M(+66.7%) |
Dec 2000 | $24.50 M(-5.9%) | $24.50 M(-35.5%) |
Sept 2000 | - | $37.99 M(-24.1%) |
June 2000 | - | $50.05 M(+70.7%) |
Mar 2000 | - | $29.33 M(+12.7%) |
Dec 1999 | $26.03 M(-15.5%) | $26.03 M(-34.8%) |
Sept 1999 | - | $39.90 M(+128.0%) |
June 1999 | - | $17.50 M(-33.0%) |
Mar 1999 | - | $26.10 M(-15.3%) |
Dec 1998 | $30.80 M(+69.2%) | $30.80 M(-10.5%) |
Sept 1998 | - | $34.40 M(+9.9%) |
June 1998 | - | $31.30 M(+18.1%) |
Mar 1998 | - | $26.50 M(+45.6%) |
Dec 1997 | $18.20 M(-45.0%) | $18.20 M(-29.7%) |
Sept 1997 | - | $25.90 M(-11.9%) |
June 1997 | - | $29.40 M(-3.3%) |
Mar 1997 | - | $30.40 M(-8.2%) |
Dec 1996 | $33.10 M | $33.10 M(-38.0%) |
Sept 1996 | - | $53.40 M(-3.8%) |
June 1996 | - | $55.50 M(+630.3%) |
Mar 1996 | - | $7.60 M |
FAQ
- What is CASI Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is CASI Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is CASI Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CASI is $17.08 M
What is the all time high annual cash & cash equivalents for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual cash & cash equivalents is $84.20 M
What is CASI Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CASI annual cash & cash equivalents has changed by -$30.03 M (-63.74%)
What is CASI Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CASI is $16.54 M
What is the all time high quarterly cash and cash equivalents for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly cash and cash equivalents is $99.73 M
What is CASI Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, CASI quarterly cash and cash equivalents has changed by -$546.00 K (-3.20%)